Genetic liability to critically ill COVID-19 was significantly causally associated with the increased risk of HER2-positive breast cancer (odds ratios = 1.086, 95% confidence intervals = 1.015–1.162, P = .016). The gene discussed is ERBB2; the disease is breast carcinoma.